Eli Lilly defeats challenge to Alimta cancer drug patent
(Reuters) - A federal patent review board on Thursday rejected a challenge to a patent covering Eli Lilly and Co's Alimta drug to treat some lung cancers and mesothelioma.

from RSSMix.com Mix ID 8258151 http://ift.tt/2xUNZEZ
from RSSMix.com Mix ID 8258151 http://ift.tt/2xUNZEZ
Comments
Post a Comment